UTI · Medication Comparison
Nitrofurantoin vs Fosfomycin for a UTI?
Both nitrofurantoin and fosfomycin are first-line options for an uncomplicated bladder infection. Here is an honest, side-by-side look at how they compare on effectiveness, dosing, pregnancy, kidney function, and resistance, so you understand why a clinician might pick one over the other.
Is nitrofurantoin or fosfomycin more effective for an uncomplicated UTI?
In a 2018 randomized trial of 513 nonpregnant women, clinical resolution through day 28 was 70% with five-day nitrofurantoin and 58% with single-dose fosfomycin. The nitrofurantoin regimen was 100 mg three times daily, not the twice-daily Macrobid regimen commonly used in the US. That result favors the studied nitrofurantoin course; it is not a guaranteed cure rate or a direct trial of every formulation and schedule. Choice still depends on susceptibility, kidney function, pregnancy and tolerability. See online UTI treatment for Bidwell’s service limits.
How are nitrofurantoin and fosfomycin dosed for a bladder infection?
- Nitrofurantoin monohydrate/macrocrystals (Macrobid): guidelines commonly use 100 mg twice daily for five days for uncomplicated cystitis in nonpregnant women; the US label specifies seven days. Other nitrofurantoin formulations have different schedules. Take the prescribed formulation with food and follow your own prescription.
- Fosfomycin tromethamine: the US label specifies one 3 g packet for uncomplicated cystitis in women. Dissolve it in 3 to 4 ounces of water that is not hot, stir and drink immediately; it may be taken with or without food. Do not swallow the dry powder, use hot water or repeat daily doses on your own.
Fosfomycin's single-dose regimen may be easier to complete. Macrobid requires twice-daily doses; guidelines commonly use five days for selected uncomplicated bladder infections, while the US label specifies seven days. Your clinician may prescribe a different duration. Follow your own prescription.
Can you take nitrofurantoin or fosfomycin during pregnancy?
Both drugs can be options for bladder infection during pregnancy after obstetric assessment, but neither treats kidney infection. ACOG considers nitrofurantoin reasonable in the first trimester when no appropriate alternative is available and advises avoiding it in people with G6PD deficiency; the Macrobid label contraindicates it at term (38 to 42 weeks), during labor and delivery, or when labor is imminent. Bidwell does not treat pregnancy UTIs.
How does kidney function affect the choice between nitrofurantoin and fosfomycin?
Kidney function affects both safety and drug exposure. The US Macrobid label lists creatinine clearance below 60 mL/min as a contraindication, while the EAU guideline uses an eGFR below 30 mL/min/1.73 m² threshold. These are different recommendations and measures, not an automatic online eligibility rule. A clinician must reconcile the applicable label, guidance and individual kidney function. Fosfomycin is not an automatic substitute in significant kidney disease. Neither drug is appropriate for suspected kidney infection.
What about antibiotic resistance?
Resistance varies by organism, geography and prior antibiotic exposure. A previous susceptible culture can help, but neither drug covers every urinary pathogen. Culture and reassessment matter when symptoms recur or treatment fails. See clinical protocols for Bidwell’s prescribing boundaries.
When is nitrofurantoin preferred and when is fosfomycin preferred?
- Nitrofurantoin may fit a susceptible uncomplicated bladder infection when kidney function and individual risks allow a multi-day course. Fosfomycin may be selected when susceptibility, tolerability and the benefit of one dose favor it. Local resistance and previous culture results matter; allergy or impaired kidney function does not automatically establish the best substitute. Neither treats kidney infection.
- Fosfomycin may be considered when a single dose has a real advantage, when nitrofurantoin or TMP-SMX cannot be used because of allergy, intolerance or resistance, or when a culture shows a susceptible organism. Its convenience is weighed against the lower clinical resolution seen in the 2018 trial. In pregnancy, an obstetric clinician may choose it for a bladder infection.
- Neither treats a kidney infection, and neither is appropriate when symptoms point beyond a simple bladder infection.
When is Bidwell Health appropriate, and when is it not?
Bidwell Health is a cash-pay ($45 visit fee; medication separate) online UTI visit for eligible nonpregnant adult women ages 18 and older in our supported states (Arizona, Colorado, Connecticut, Florida, Iowa, Maryland, Montana, New Mexico, Utah, Virginia, and Washington). It can be a good fit for a straightforward lower urinary tract infection: burning with urination, urgency, frequency, and no warning signs. A provider reviews your visit information and, when it is clinically appropriate, sends a prescription such as nitrofurantoin to your pharmacy. Prescriptions are never guaranteed and are sent only when the clinical picture supports them.
Bidwell's routine online UTI service is for eligible nonpregnant women ages 18 and older in our 11 supported states. Men, children, pregnancy, suspected kidney infection, a urinary catheter, immunosuppression and other complicated infections need another care setting. Recurrent UTIs (two or more in six months or three or more in twelve months) need in-person assessment and a urine culture. A failed antibiotic course does not automatically rule out online review. A clinician reassesses your symptoms and decides whether a urine culture, other testing or an in-person examination is needed. Older age alone does not automatically exclude online care.
Seek same-day in-person care for fever of 100.4°F (38°C) or higher, chills, pain in the side or back below the ribs, severe pelvic or lower abdominal pain, nausea or vomiting, visible blood in the urine without typical bladder-infection symptoms, heavy bleeding or clots, or blood that persists after treatment. Get same-day care if urinary symptoms get worse quickly or significantly. If pregnant or possibly pregnant, contact your obstetric clinician promptly. Call 911 or go to the emergency department for confusion, fainting, trouble breathing, inability to stay awake, or severe illness; inability to urinate or inability to keep fluids down also needs urgent emergency assessment. Do not wait for an online review.
Related reading
Common questions
Is nitrofurantoin or fosfomycin more effective for an uncomplicated UTI?
In a 2018 randomized trial of 513 nonpregnant women, clinical resolution through day 28 was 70% with five-day nitrofurantoin and 58% with single-dose fosfomycin. The nitrofurantoin regimen was 100 mg three times daily, not the twice-daily Macrobid regimen commonly used in the US. That result favors the studied nitrofurantoin course; it is not a guaranteed cure rate or a direct trial of every formulation and schedule.
How are nitrofurantoin and fosfomycin dosed for a bladder infection?
Nitrofurantoin monohydrate/macrocrystals (Macrobid): guidelines commonly use 100 mg twice daily for five days for uncomplicated cystitis in nonpregnant women; the US label specifies seven days. Other nitrofurantoin formulations have different schedules. Take the prescribed formulation with food and follow your own prescription. Fosfomycin tromethamine: the US label specifies one 3 g packet for uncomplicated cystitis in women. Dissolve it in 3 to 4 ounces of water that is not hot, stir and drink immediately; it may be taken with or without food. Do not swallow the dry powder, use hot water or repeat daily doses on your own.
Can you take nitrofurantoin or fosfomycin during pregnancy?
Pregnancy treatment should be selected by the obstetric clinician after urine culture. ACOG considers nitrofurantoin reasonable in the first trimester when no appropriate alternative is available and advises avoiding it in people with G6PD deficiency; the Macrobid label contraindicates it at term (38 to 42 weeks), during labor and delivery, or when labor is imminent. Fosfomycin may be used for bladder infection, not kidney infection. Bidwell does not provide pregnancy UTI treatment.
How does kidney function affect the choice between nitrofurantoin and fosfomycin?
Kidney function affects both safety and drug exposure. The US Macrobid label lists creatinine clearance below 60 mL/min as a contraindication, while the EAU guideline uses an eGFR below 30 mL/min/1.73 m² threshold. These are different recommendations and measures, not an automatic online eligibility rule. A clinician must reconcile the applicable label, guidance and individual kidney function. Fosfomycin is not an automatic substitute in significant kidney disease.
When is nitrofurantoin preferred and when is fosfomycin preferred?
The choice depends on susceptibility, kidney function, allergy and other individual risks. Nitrofurantoin is a common multi-day option; fosfomycin offers a single dose but is not always equally effective. Prior cultures and local resistance matter. Neither treats kidney infection.
When is Bidwell Health not appropriate for a UTI?
Bidwell's routine online UTI service is for eligible nonpregnant women ages 18 and older in our 11 supported states. Men, children, pregnancy, suspected kidney infection, a urinary catheter, immunosuppression and other complicated infections need another care setting. Recurrent UTIs (two or more in six months or three or more in twelve months) need in-person assessment and a urine culture. A failed antibiotic course does not automatically rule out online review. A clinician reassesses your symptoms and decides whether a urine culture, other testing or an in-person examination is needed. Older age alone does not automatically exclude online care. Seek same-day in-person care for fever of 100.4°F (38°C) or higher, chills, back or flank pain, nausea or vomiting, severe pelvic or lower abdominal pain, visible blood in the urine without typical bladder-infection symptoms, heavy bleeding or clots, or blood that persists after treatment. Get same-day care if urinary symptoms get worse quickly or significantly. Call 911 for severe illness.
Sources checked for this update
- Huttner et al., JAMA 2018: randomized nitrofurantoin/fosfomycin trial
- DailyMed: Macrobid prescribing information
- DailyMed: fosfomycin tromethamine prescribing information
- ACOG: urinary tract infections in pregnant individuals
- EAU 2026: urological infections guideline
These sources support the educational updates. They do not replace individual clinical assessment.